SLC6A3 and attention deficit-hyperactivity disorder: Besides the above-mentioned evidence, the involvement of neurotransmitter systems in ADHD is reinforced by the mechanism of action of most drugs used for its treatment that involves targets related to these biological pathways (e.g., methylphenidate, which targets DAT and NET).